# Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

> **NCT02642562** · PHASE4 · COMPLETED · sponsor: **University of Glasgow** · enrollment: 1160 (estimated)

## Conditions studied

- Chronic Heart Failure
- Iron Deficiency
- Left Ventricular Systolic Dysfunction

## Interventions

- **DRUG:** Ferric Derisomaltose

## Key facts

- **NCT ID:** NCT02642562
- **Lead sponsor:** University of Glasgow
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-08-26
- **Target enrollment:** 1160 (ESTIMATED)
- **Last updated:** 2022-10-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642562, "Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02642562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*